Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AXSM

Axsome Therapeutics Inc

May 13 • 04:00PM ET

235.32

+11.29 5.04 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: NBIX ALKS ACAD DNLI NMRA

| Held by: VTI IWM VB FBT VBK VXF IWO IBB SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.74	Insider Own	16.02%	Shs Outstand	51.42M	Perf Week	5.70%
Market Cap	12.11B	Forward P/E	40.72	EPS next Y	5.78	Insider Trans	-4.42%	Shs Float	43.21M	Perf Month	27.77%
Enterprise Value	12.02B	PEG	-	EPS next Q	-0.84	Inst Own	75.29%	Short Float	6.36%	Perf Quarter	26.37%
Income	-188.30M	P/S	17.10	EPS this Y	46.68%	Inst Trans	0.19%	Short Ratio	3.89	Perf Half Y	70.77%
Sales	708.24M	P/B	221.67	EPS next Y	394.56%	ROA	-28.74%	Short Interest	2.75M	Perf YTD	28.84%
Book/sh	1.06	P/C	39.69	EPS next 5Y	-	ROE	-349.38%	52W High	234.29 0.44%	Perf Year	122.69%
Cash/sh	5.93	P/FCF	-	EPS past 3/5Y	7.17% -5.89%	ROIC	-93.84%	52W Low	96.09 144.90%	Perf 3Y	197.84%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	133.68% -	Gross Margin	91.30%	Volatility	3.51% 4.66%	Perf 5Y	292.00%
Dividend TTM	-	EV/Sales	16.98	EPS Y/Y TTM	35.18%	Oper. Margin	-24.93%	ATR (14)	9.11	Perf 10Y	2109.58%
Dividend Ex-Date	-	Quick Ratio	1.32	Sales Y/Y TTM	63.88%	Profit Margin	-26.59%	RSI (14)	78.70	Recom	1.24
Dividend Gr. 3/5Y	- -	Current Ratio	1.39	EPS Q/Q	-3.69%	SMA20	16.11%	Beta	0.59	Target Price	270.89
Payout	-	Debt/Eq	4.03	Sales Q/Q	57.42%	SMA50	30.47%	Rel Volume	1.15	Prev Close	224.03
Employees	925	LT Debt/Eq	2.68	Earnings	May 04 BMO	SMA200	54.58%	Avg Volume	707.16K	Price	235.32
IPO	Nov 19, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-49.22% -0.79%	Trades		Volume	815,448	Change	5.04%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)